Ohio State University
920
158
243
498
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.3%
104 terminated/withdrawn out of 920 trials
82.7%
-3.8% vs industry average
9%
82 trials in Phase 3/4
45%
222 of 498 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (920)
Complex Rehabilitation Technology Enabled Physical Activity for Children With Motor Delays Via Telehealth in Natural Environments
Role: lead
Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia
Role: lead
Suicide Prevention for Substance Using Youth Experiencing Homelessness
Role: lead
Implementation of TBI-RECOVER in Substance Use Treatment
Role: lead
The SCOPE Trial: Sleep, Cognition, and Pain Bundle vs. ERAS-cardiac for Postoperative Delirium
Role: collaborator
Kidney Precision Medicine Project
Role: collaborator
Mindfulness in Motion Targeted to Sustaining the Mental and Physical Resilience of First Responders
Role: lead
Using Life's Essential 8 in Midlife Black Women
Role: lead
The PulsePoint Study
Role: collaborator
Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients
Role: lead
A Prospective Observational Study of TPIAT
Role: collaborator
Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis
Role: collaborator
MOON Shoulder Instability-Cohort of Patients Undergoing Operative Treatment.
Role: collaborator
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
Role: collaborator
Marrow Cellution™ vs. Traditional BMA Harvest Project
Role: lead
Evaluation of Healing Following Open Gluteus Medius Repair With Biointegrative Implant
Role: lead
Teen Driving Translation Study (NIH)
Role: collaborator
The Spine Phenome Project
Role: lead
Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)
Role: lead
Feasibility and Reliability of the Melbourne Assessment-2 (MA-2) for Telehealth
Role: lead